Fox Chase Researcher Shares NIH Grant to Study Palliative Care in Head and Neck Cancer
ASCO 2019: Targeting Resistant Adenoid Cystic Carcinoma With Apatinib
ASCO 2019: Phase II Basket Trial of T-DM1 in Salivary Gland Cancers
Pembrolizumab Approved for First-Line Treatment of Head and Neck Squamous Cell Carcinoma
How Common Are Skin Lesions in Oral Cavity Squamous Cell Carcinoma?
Factors Affecting Survival in Advanced Head/Neck Cutaneous Squamous Cell Carcinoma
Treatment Deintensification for p16-Positive Oropharyngeal Cancer
Can Tumor-Type HPV DNA in Oral/Throat Cancers After Treatment Predict Recurrence?
Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have? (login required)
Management of Head & Neck Cancer at Disease Progression: Now What? (login required)
JADPRO Regional Lectures: Immunotherapy: Head & Neck Case Studies
Expanding Treatment Horizons in Head and Neck Cancer: TRK Inhibitors (login required)
Vanderbilt-Ingram Cancer Center
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Duke Cancer Institute
University of Wisconsin Carbone Cancer Center
Cetuximab (Head and Neck Cancers)
Support for People with Oral and Head and Neck Cancer (SPOHNC)
American Head & Neck Society (AHNS)
ThyCa: Thyroid Cancer Survivors’ Association, Inc.
NCCN Guidelines for Patients®: Thyroid Cancer